Solventum (SOLV), the healthcare company spun off from 3M (MMM) earlier this year, has retained bankers to explore a sale of its purification and filtration business, people familiar with the matter told The Wall Street Journal’s Lauren Thomas. Solventum is expected to draw takeover interest from private equity and strategic buyers, the sources said.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.